High dose ipilimumab (Ipi) plus temozolomide (TMZ) after progression on standard or low dose Ipi in advanced melanoma
Williamson, Julie, Hidayatullah Fadlullah, Muhammad Zaki, Kovacsovics, Magdalena, Gibson, Berit, Erickson-Wayman, Alyssa, Jamison, Debra, Sageser, Daniel S., Swami, Umang, Jeter, Joanne M., Bowles, Tawnya Lynn, Cannon, Donald Maurice, Haaland, Ben, Schroeder, Joyce, McPherson, Jordan P., Hyngstrom, John Robert, Tan, Aik-choon, Hu-Lieskovan, Siwen
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Response to high dose ipilimumab plus temozolomide after progression on standard or low dose ipilimumab in advanced melanoma: a retrospective analysis
Williamson, Julie, Fadlullah, Muhammad Zaki Hidayatullah, Kovacsovics-Bankowski, Magdalena, Gibson, Berit, Swami, Umang, Erickson-Wayman, Alyssa, Jamison, Debra, Sageser, Dan, Jeter, Joanne, Bowles, Tawnya, Cannon, Donald M, Haaland, Ben, Schroeder, Joyce D, Nix, David, Atkinson, Aaron, Hyngstrom, John, McPherson, Jordan, Tan, Aik-Choon, Hu-Lieskovan, Siwen
Published in Research square (01.06.2023)
Get more information
Published in Research square (01.06.2023)
Journal Article